Both BTK and the related TEC kinases ETK and BMX are abundantly expressed in prostate cancer cells, and knockdown of BTK expression in prostate cancer cells results in reduced proliferative activity (Guo et al., 2014; Kokabee et al., 2015; Chen et al., 2018). This evidence concerns the gene BTK and prostate cancer.